First-line treatment of EGFR-mutated nonsmall cell lung cancer : critical review on study methodology
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: European respiratory review, 23.2014. Nr. 131, S. 92-105, doi:10.1183/09059180.00008413
- Keyword
-
Krebs
Onkologie
- Event
-
Veröffentlichung
- (where)
-
Frankfurt am Main
- (who)
-
Universitätsbibliothek Johann Christian Senckenberg
- (when)
-
2014
- Creator
- URN
-
urn:nbn:de:hebis:30:3-355567
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:49 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sebastian, Martin
- Schmittel, Alexander
- Reck, Martin
- Universitätsbibliothek Johann Christian Senckenberg
Time of origin
- 2014
Other Objects (12)
Afatinib as first-line treatment in patients with EGFR-mutated non-small cell lung cancer in routine clinical practice
Impact of BET bromodomain inhibition on KRAS-mutated non-small cell lung cancer
Non-small cell lung cancer treatment
Non-small cell lung cancer treatment
Non-small cell lung cancer treatment
EGFR signaling in lung fibrosis
Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in Germany
The circular RNA landscape of non-small cell lung cancer cells
Targeted cytokine-induced killer cells in non-small cell lung cancer
Induction of Acquired Resistance towards EGFR Inhibitor Gefitinib in a Patient-Derived Xenograft Model of Non-Small Cell Lung Cancer and Subsequent Molecular Characterization
Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer
Hypoxia-Induced Radioresistance in Human Non-Small Cell Lung Carcinoma Cell Lines
Afatinib as first-line treatment in patients with EGFR-mutated non-small cell lung cancer in routine clinical practice
Impact of BET bromodomain inhibition on KRAS-mutated non-small cell lung cancer
Non-small cell lung cancer treatment
Non-small cell lung cancer treatment
Non-small cell lung cancer treatment
EGFR signaling in lung fibrosis
Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in Germany
The circular RNA landscape of non-small cell lung cancer cells
Targeted cytokine-induced killer cells in non-small cell lung cancer
Induction of Acquired Resistance towards EGFR Inhibitor Gefitinib in a Patient-Derived Xenograft Model of Non-Small Cell Lung Cancer and Subsequent Molecular Characterization
Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer
Hypoxia-Induced Radioresistance in Human Non-Small Cell Lung Carcinoma Cell Lines
Afatinib as first-line treatment in patients with EGFR-mutated non-small cell lung cancer in routine clinical practice
Impact of BET bromodomain inhibition on KRAS-mutated non-small cell lung cancer
Non-small cell lung cancer treatment
Non-small cell lung cancer treatment
Non-small cell lung cancer treatment
EGFR signaling in lung fibrosis
Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in Germany
The circular RNA landscape of non-small cell lung cancer cells
Targeted cytokine-induced killer cells in non-small cell lung cancer
Induction of Acquired Resistance towards EGFR Inhibitor Gefitinib in a Patient-Derived Xenograft Model of Non-Small Cell Lung Cancer and Subsequent Molecular Characterization
Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer